Phase IIa Clinical Trials

Connecting you with the right people to speed your development.

At this stage, the right data will show regulators and investors that your new molecule is effective and ready to progress. Therefore, access to focused support is critical to generating relevant data.

Phase II is sometimes broken down further into Phase IIa and Phase IIb. During Phase IIa clinical trials, we are specifically focused on determining dosage requirements. A group of patients is administered the drug in various quanitites to investigate dosage and optimal frequency of doses. 

Phase IIb trials are specifically focused on testing the efficacy of the drug and determining how successful it is in terms of treatment, prevention, and diagnosing a disease. 

Our early product development team delivers Phase 2a clinical trials by offering the speed and dexterity of transnational medicine experts, while also being supported by a global scientific, regulatory, and clinical organization.

Patient Recruitment

Learn more about our patient recruitment and retention services.

Learn More

The FSP Workforce of the Future: Spotlight on CRAs

Watch Now

Real-world evidence for more efficent, patient-focused trials

View Now

Innovating for the future of drug development

View Now

PharmaVOICE RWE Showcase -The RWE Evolution

View Now

Top Ten Rules for Success in DCTs

View Now

We are always available for a conversation.

Submitting...

Communication Preference

Communication Preference